Partos, Laura L.
HRN: 21 51 59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/03/2022
07/10/2022
IVT
4.5g
Q6h
UTI- Progressing
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes